SCHEMBL7315904

SCHEMBL7315904

Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cccc(OCCN3CCOCC3)c2)C(=O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 4/20 0.58
ITGB1 P05556 6/20 0.48
ITGA2 P17301 1/20 0.48
ALDH1A1 P00352 1/20 0.48
ITGA5 P08648 3/20 0.48
FKBP1A P62942 3/20 0.46
ITGB7 P26010 1/20 0.46
ITGAV P06756 1/20 0.44
FKBP5 Q13451 3/20 0.44
FKBP4 Q02790 2/20 0.44
HCRTR1 O43613 2/20 0.43
HCRTR2 O43614 2/20 0.43
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43
TSHR P16473 1/20 0.43
MMP1 P03956 1/20 0.43
MMP9 P14780 1/20 0.43
MMP13 P45452 1/20 0.43
ADAM17 P78536 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7316261 0.94 ITGA4 (0.59) ITGA4ITGB1ITGA2ALDH1A1ITGA5
SCHEMBL7321689 0.91 ITGA4 (0.65) ITGA4ITGB1ITGA2ALDH1A1ITGA5
SCHEMBL7322764 0.86 ITGA4 (0.53) ITGA4ITGB1ITGA2ALDH1A1ITGA5
SCHEMBL7509325 0.85 ITGA4 (0.49) ITGA4ITGB1ITGA2ALDH1A1ITGA5
SCHEMBL7314294 0.85 ITGA4 (0.66) ITGA4ITGB1ITGA2ALDH1A1ITGA5
SCHEMBL9068818 0.84 ITGA4 (0.56) ITGA4ITGB1ITGA2ALDH1A1ITGA5
SCHEMBL7315890 0.84 ITGA4 (0.65) ITGA4ITGB1ITGA2ALDH1A1ITGA5
SCHEMBL7317528 0.84 ITGA4 (0.65) ITGA4ITGB1ITGA2ALDH1A1ITGA5
SCHEMBL7320248 0.83 ITGA4 (0.56) ITGA4ITGB1ITGA2ALDH1A1ITGA5
SCHEMBL7510457 0.82 ITGA4 (0.63) ITGA4ITGB1ITGA2ALDH1A1ITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US claimed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed